Journal of Pharma and Drug Innovation

Frequency : Quarterly
Editorial & Review Timeline
3 - 9 Days Initial Quality Review
14 Days Peer Evaluation Summary
80% Final Acceptance Rate After Peer Review
35 - 45 Days Complete Editorial Processing Time

Fereshteh Nazari Khanamiri

Pharm.D.

Fereshteh Nazari Khanamiri is a 27-year-old pharmacist and researcher specializing in targeted drug delivery, phytotherapy, and pharmacology. She has published more than 10 scientific articles, holds an h-index of 7, and has received approximately 250 citations. She also serves as a peer reviewer for Springer Nature and other journals. Her research focuses on nanoparticles, extracellular vesicles, and RNA-based therapeutics. In addition to her academic work, she manages her own pharmacy and is passionate about high-impact, innovative scientific projects.

  • Reviewer, Basic & Clinical Pharmacology and Toxicology Journal (2024–present)

  • NODAK Start-up Fellow

  • Research Team Leader, Cellular & Molecular Medicine Institute

  • Research Associate, Urmia University of Medical Sciences

  • Teaching research methods & biology

    F.N.Kh last version C.V-2

A total of 13+ published articles (wet lab, reviews, systematic reviews, hypotheses) + 2 manuscripts under review + 1 book chapter.
Full list provided in CV.